2026 Jeffrey B. Ulmer: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	75	1968	1802	51	42	200	23750

Jeffrey B. Ulmer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jeffrey B. Ulmer sits on this spectrum.

62 publications 807+

This scientist: 200 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jeffrey B. Ulmer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey B. Ulmer sits on this spectrum.

40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jeffrey B. Ulmer is affiliated with Novartis in Switzerland and contributes extensively to scientific research in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work spans several subfields, including Infectious Diseases, Molecular Biology, Epidemiology, Neurology, and Immunology.

The research topics that Jeffrey B. Ulmer has contributed to focus mainly on viral infections and vaccine technology. These topics include:

SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
Viral gastroenteritis research and epidemiology
RNA Interference and Gene Delivery
Long-Term Effects of COVID-19
Vaccines and immunoinformatics approaches
Respiratory viral infections research

Ulmer's recent publications highlight involvement in vaccine development and pandemic prevention. Notable recent papers include:

"Stopping pandemics before they start: Lessons learned from SARS-CoV-2," 2022, published in Science
"Development of a potent Zika virus vaccine using self-amplifying messenger RNA," 2020, published in Science Advances
"A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models," 2022, published in Molecular Therapy
"Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action," 2021, published in Current topics in microbiology and immunology
"Antibody-guided structure-based vaccines," 2020, published in Seminars in Immunology

Frequent collaborators with whom Ulmer has co-authored multiple papers include Lbachir BenMohamed, Swayam Prakash, Hawa Vahed, Daniel Gil, and Nisha R. Dhanushkodi.

Many of Ulmer's research articles have been published in prominent venues such as bioRxiv (Cold Spring Harbor Laboratory), hosting six of their works, as well as Frontiers in Immunology, Science, Science Advances, and Molecular Therapy.

Best Publications

Heterologous protection against influenza by injection of DNA encoding a viral protein

Jeffrey B. Ulmer;John J. Donnelly;Suezanne E. Parker;Gary H. Rhodes

3401
Citations
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

Georg Widera;Melissa Austin;Dietmar Rabussay;Cheryl Goldbeck

964
Citations
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

Huygen K;Denis O;Montgomery Dl

928
Citations
Targeting the innate immune response with improved vaccine adjuvants

Achal Pashine;Nicholas M Valiante;Jeffrey B Ulmer

720
Citations
Nonviral delivery of self-amplifying RNA vaccines

Andrew J. Geall;Ayush Verma;Gillis R. Otten;Christine A. Shaw

712
Citations
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Giulietta Maruggi;Cuiling Zhang;Junwei Li;Jeffrey B. Ulmer

523
Citations
Vaccine manufacturing: challenges and solutions

Jeffrey B Ulmer;Ulrich Valley;Rino Rappuoli

494
Citations
Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

John J. Donnelly;Arthur Friedman;Douglas Martinez;Donna L. Montgomery

473
Citations
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.

Marc Dupuis;Kimberly Denis-Mize;Carolyn Woo;Cheryl Goldbeck

453
Citations
Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

T.-M. Fu;J. B. Ulmer;M. J. Caulfield;R. R. Deck

419
Citations
Polynucleotide tuberculosis vaccine

Kris Huygen;Margaret A. Liu;Donna Montgomery

413
Citations
Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors

Donna L. Montgomery;John W. Shiver;Karen R. Leander;Helen C. Perry

403
Citations
Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis

Susan L. Baldwin;Celine D’Souza;Alan D. Roberts;Brian P. Kelly

391
Citations
Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells.

J. B. Ulmer;R. R. Deck;C. M. Dewitt;J. J. Donnelly

380
Citations
PROTECTIVE CD4+ AND CD8+ T CELLS AGAINST INFLUENZA VIRUS INDUCED BY VACCINATION WITH NUCLEOPROTEIN DNA

Jeffrey B. Ulmer;Tong-Ming Fu;R. Randall Deck;Arthur Friedman

370
Citations
The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

S. W. Barnett;S. Lu;I. Srivastava;S. Cherpelis

352
Citations
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Luis A Brito;Michelle Chan;Christine A Shaw;Armin Hekele

338
Citations
Immunization of non-human primates with DNA vaccines

Margaret A. Liu;William McClements;Jeffrey B. Ulmer;John Shiver

337
Citations
Human clinical trials of plasmid DNA vaccines.

Margaret A Liu;Jeffrey B Ulmer

276
Citations
Mechanism of action of mRNA-based vaccines

Carlo Iavarone;Derek T. O’hagan;Dong Yu;Nicolas F. Delahaye

265
Citations
Vaccination with Plasmid DNA Encoding Mycobacterial Antigen 85A Stimulates a CD4+ and CD8+ T-Cell Epitopic Repertoire Broader than That Stimulated by Mycobacterium tuberculosis H37Rv Infection

Olivier Denis;Audrey Tanghe;Kamiel Palfliet;Fabienne Jurion

259
Citations

Frequent Co-Authors

John J. Donnelly Novartis (United States)

Margaret A. Liu Karolinska Institute

John W. Shiver United States Military Academy

Susan W. Barnett Bill & Melinda Gates Foundation

Kris Huygen Institut Pasteur

Derek O'hagan GlaxoSmithKline (United Kingdom)

Manmohan Singh Beam Therapeutics

Rino Rappuoli Imperial College London

Nicholas M. Valiante Novartis (Switzerland)

Christian W. Mandl Novartis (Switzerland)

External Links

Personal website of Jeffrey B. Ulmer

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in complementing their studies in Immunology with practical healthcare roles, exploring related nursing programs can be beneficial. Many students seek "easy LPN programs to get into" as a stepping stone toward advanced nursing careers. These programs offer accessible entry points for gaining essential clinical skills.

Advancing from LPN to Nurse Practitioner is a common pathway, and selecting "which nurse practitioner program is easiest" can help streamline your educational journey without compromising quality. This approach allows students to efficiently build expertise in patient care, including immunological aspects.

For specialized mental health care, "best PMHNP programs" provide comprehensive training that combines clinical practice with psychiatric nursing, often including strong immunology components related to neuroinflammation and immune responses in mental health.

Budget-conscious students may consider "cheap psych NP programs," which offer affordable options without sacrificing program quality or clinical placement opportunities. These degrees position graduates for diverse career opportunities, including psychiatric nursing and immunology-related research.